• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.66% Nasdaq Up 0.88%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    27.19 Up 1.34(5.18%) May 2, 4:00PM EDT
    Prev Close:25.85
    Open:25.86
    Bid:N/A
    Ask:27.88 x 100
    1y Target Est:41.33
    Beta:1.13489
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:25.42 - 27.22
    52wk Range:24.83 - 43.63
    Volume:709,070
    Avg Vol (3m):849,611
    Market Cap:1.24B
    P/E (ttm):108.76
    EPS (ttm):0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORUp 5.18%1.24B
    BIIBDown 0.47%59.95B

    Key Statistics

    Forward P/E (1 yr):28.32
    P/S (ttm):2.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.73
    Quarterly EPS Est (Jun-16) :0.20
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):1.28

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback